{
  "docId": "019dd923-622c-750b-8b9a-4b91788fc785",
  "docSlug": "5fadb686cc03",
  "documentTitle": "Twist Bioscience (TWST)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2022-11-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 208,
  "pageCount": 236,
  "prevPage": 207,
  "nextPage": 209,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Includes a quote from an industry expert and a chart comparing sequencing costs to Moore's Law.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "line_chart",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-4b91788fc785/208",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785#slide-208",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.44,
        "x": 0.52,
        "y": 0.53
      },
      "kind": "callout",
      "text": "A $100 genome? New DNA sequencers could be a ‘game changer’ for biology, medicine. This is the year of the big shake-up. Ultima Genomics Claims the $100 Genome and Raises $600M to Go Even Lower",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9a4505a-93d4-442b-b223-f97bcb48c3ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "The only point of Twist's NGS offering is to sequence a small part of the genome given the cost of the entire genome.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0933-75bb-9bf5-974eba50903c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.44,
        "x": 0.06,
        "y": 0.53
      },
      "kind": "chart",
      "text": "Cost per Raw Megabase of DNA Sequence",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf868037-6495-4896-8a39-86e232b33272",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Cost per Raw Megabase: $100",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-0933-75bb-9bf5-9f957b90a372",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "paragraph",
      "text": "The cost of whole genome sequencing has fallen much faster than Moore’s law, with players already targeting a cost <$100 vs. $10K and $1K ten and five years ago, respectively. The only point of Twist's NGS offering is to sequence a small part of the genome given the cost of the entire genome. As the previous expert indicated: “Why would you do pools anymore if you get the whole genome for $100? There’s no use buying something to do a panel, which will cost you $20 when the whole genome is $100. So, I’d be worried about enzymatic DNA synthesis. I’d be worried about the desktop synthesis. And I’d be real worried about the price of whole genome sequencing.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26a37008-51f1-4345-8adb-eebaa186aa6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Why would you do pools anymore if you get the whole genome for $100? There’s no use buying something to do a panel, which will cost you $20 when the whole genome is $100. So, I’d be worried about enzymatic DNA synthesis. I’d be worried about the desktop synthesis. And I’d be real worried about the price of whole genome sequencing. — Previous expert",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0933-75bb-9bf5-98bb44ce2fdc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: https://www.science.org/content/article/100-genome-new-dna-sequencers-could-be-a-game-changer-biology-medicine; https://singularityhub.com/2022/06/05/ultima-genomics-claims-the-100-genome-and-raises-600m-to-go-even-lower/; https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8b018e2-0066-4d72-9528-ebbbcaf8b82e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "8c9a7d48-618c-4205-afd9-591b4966a63b",
      "evidence": "Uses an expert quote to contradict the business model of the target company.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}